Availability of oral antivirals against SARS-CoV-2 infection and the requirement for an ethical prescribing approach

R Dal-Ré, SL Becker, E Bottieau… - The Lancet Infectious …, 2022 - thelancet.com
The first two oral antivirals, molnupiravir and nirmatrelvir–ritonavir, are now becoming
available in many countries. These medicines will be indicated to treat mild-to-moderate …
被引用次数：59 相关文章

Availability of oral antivirals against SARS-CoV-2 infection and the requirement for an ethical prescribing approach.

R Dal-Ré, SL Becker, E Bottieau… - The Lancet. Infectious …, 2022 - europepmc.org
The first two oral antivirals, molnupiravir and nirmatrelvir–ritonavir, are now becoming
available in many countries. These medicines will be indicated to treat mild-to-moderate …

Availability of oral antivirals against SARS-CoV-2 infection and the requirement for an ethical prescribing approach

R Dal-Ré, SL Becker, E Bottieau, S Holm - The Lancet Infectious Diseases, 2022 - Elsevier
The first two oral antivirals, molnupiravir and nirmatrelvir–ritonavir, are now becoming
available in many countries. These medicines will be indicated to treat mild-to-moderate …

Availability of oral antivirals against SARS-CoV-2 infection and the requirement for an ethical prescribing approach

R Dal-Ré, SL Becker, E Bottieau… - The Lancet. Infectious …, 2022 - research.manchester.ac.uk
The first two oral antivirals, molnupiravir and nirmatrelvir-ritonavir, are now becoming
available in many countries. These medicines will be indicated to treat mild-to-moderate …

Availability of oral antivirals against SARS-CoV-2 infection and the requirement for an ethical prescribing approach

R Dal-Ré, SL Becker, E Bottieau… - The Lancet. Infectious …, 2022 - pubmed.ncbi.nlm.nih.gov
The first two oral antivirals, molnupiravir and nirmatrelvir-ritonavir, are now becoming
available in many countries. These medicines will be indicated to treat mild-to-moderate …

Availability of oral antivirals against SARS-CoV-2 infection and the requirement for an ethical prescribing approach

R Dal-Ré, SL Becker, E Bottieau, S Holm - 2022 - jahrbib.sulb.uni-saarland.de
The first two oral antivirals, molnupiravir and nirmatrelvir–ritonavir, are now becoming
available in many countries. These medicines will be indicated to treat mild-to-moderate …
[HTML] nih.gov

[HTML][HTML] Availability of oral antivirals against SARS-CoV-2 infection and the requirement for an ethical prescribing approach

R Dal-Ré, SL Becker, E Bottieau… - The Lancet. Infectious …, 2022 - ncbi.nlm.nih.gov
The first two oral antivirals, molnupiravir and nirmatrelvir–ritonavir, are now becoming
available in many countries. These medicines will be indicated to treat mild-to-moderate …

Availability of oral antivirals against SARS-CoV-2 infection and the requirement for an ethical prescribing approach

R Dal-Ré, SL Becker, E Bottieau, S Holm - 2022 - publikationen.sulb.uni-saarland.de
The first two oral antivirals, molnupiravir and nirmatrelvir–ritonavir, are now becoming
available in many countries. These medicines will be indicated to treat mild-to-moderate …

[引用][C] Availability of oral antivirals against SARS-CoV-2 infection and the requirement for an ethical prescribing approach

R Dal-Ré, SL Becker, E Bottieau, S Holm - The Lancet Infectious …, 2022 - cir.nii.ac.jp
Availability of oral antivirals against SARS-CoV-2 infection and the requirement for an ethical
prescribing approach | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細 …

Availability of oral antivirals against SARS-CoV-2 infection and the requirement for an ethical prescribing approach.

R Dal-Ré, SL Becker, E Bottieau… - The Lancet. Infectious …, 2022 - europepmc.org
The first two oral antivirals, molnupiravir and nirmatrelvir–ritonavir, are now becoming
available in many countries. These medicines will be indicated to treat mild-to-moderate …